Literature DB >> 8397115

A role for protein kinase C-epsilon in angiotensin II stimulation of phospholipase D in rat renal mesangial cells.

J Pfeilschifter1, A Huwiler.   

Abstract

The role of Ca2+ and protein kinase C (PKC) in the regulation of phosphatidylcholine-hydrolyzing phospholipase D (PLD) was investigated in angiotensin II-stimulated mesangial cells. Elevation of cytosolic free Ca2+ by the calcium ionophore, A23187, or the Ca(2+)-ATPase inhibitor, thapsigargin, slightly increased PLD-stimulated phosphatidylethanol formation. However, chelation of cytosolic Ca2+ with high concentrations of quin 2 did not attenuate angiotensin II-induced phosphatidylethanol production, thus suggesting that Ca2+ is not crucially involved in agonist-stimulated PLD activation. Stimulation of PKC by phorbol esters increased PLD activity in mesangial cells. Down-regulation of PKC-alpha and -delta isoenzymes by 8 h phorbol ester treatment still resulted in full PLD activation. In contrast, a 24 h treatment of mesangial cells with phorbol ester, a regimen that also causes depletion of PKC-epsilon, abolished angiotensin II-evoked phosphatidylethanol formation. In addition, the selective PKC inhibitor, calphostin C, attenuated hormone-induced PLD activity. In summary, these data suggest that angiotensin II stimulation of phospholipase D appears to involve the PKC-epsilon isoenzyme, activated by DAG derived from phosphoinositide hydrolysis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8397115     DOI: 10.1016/0014-5793(93)80350-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  9 in total

1.  Angiotensin II activation of protein kinase C decreases delayed rectifier K+ current in rabbit vascular myocytes.

Authors:  O Clément-Chomienne; M P Walsh; W C Cole
Journal:  J Physiol       Date:  1996-09-15       Impact factor: 5.182

2.  Protein phosphatase inhibitors exert specific and nonspecific effects on calcium influx in thapsigargin-treated human neutrophils.

Authors:  K Wong; X B Li
Journal:  Inflammation       Date:  1998-12       Impact factor: 4.092

3.  Concerted action of cytosolic Ca2+ and protein kinase C in receptor-mediated phospholipase D activation in Chinese hamster ovary cells expressing the cholecystokinin-A receptor.

Authors:  R R Bosch; R L Smeets; F Sleutels; A M Patel; S E Emst-de Vries; J Joep; H H de Pont; P H Willems
Journal:  Biochem J       Date:  1999-01-15       Impact factor: 3.857

4.  Heterologous desensitization of the sphingosine-1-phosphate receptors by purinoceptor activation in renal mesangial cells.

Authors:  Cuiyan Xin; Shuyu Ren; Josef Pfeilschifter; Andrea Huwiler
Journal:  Br J Pharmacol       Date:  2004-10-04       Impact factor: 8.739

5.  Bradykinin stimulates phospholipase D in PC12 cells by a mechanism which is independent of increases in intracellular Ca2+.

Authors:  J Horwitz; B Passarello; M Corso
Journal:  Neurochem Res       Date:  1995-09       Impact factor: 3.996

6.  Selective down-regulation of protein kinase c-epsilon by carcinogens does not prevent stimulation of phospholipase D by phorbol ester and platelet-derived growth factor.

Authors:  Z Kiss; W H Anderson
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

7.  Phospholipase D-induced phosphatidate production in intact small arteries during noradrenaline stimulation: involvement of both G-protein and tyrosine-phosphorylation-linked pathways.

Authors:  D T Ward; J Ohanian; A M Heagerty; V Ohanian
Journal:  Biochem J       Date:  1995-04-15       Impact factor: 3.857

8.  Stimulation by extracellular ATP and UTP of the mitogen-activated protein kinase cascade and proliferation of rat renal mesangial cells.

Authors:  A Huwiler; J Pfeilschifter
Journal:  Br J Pharmacol       Date:  1994-12       Impact factor: 8.739

9.  Possible role of protein kinase C-epsilon isoenzyme in inhibition of interleukin 1 beta induction of nitric oxide synthase in rat renal mesangial cells.

Authors:  H Mühl; J Pfeilschifter
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.